drugset / Trial / NCT06854276
Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies
RandomizedParallel-groupTriple-blindTreatment
Summary
This study employs a multicenter, randomized, open-label, positive drug-controlled, multiple ascending dose clinical trial design to comprehensively evaluate the safety, tolerability, immunogenicity, and pharmacokinetic characteristics of SSS06 injection in patients with chemotherapy-induced anemia from non-myeloid malignancies, while also exploring its potential efficacy.
Timeline
- Start
- 2025-03-01
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SSS06 | Protein / enzyme biologic | 200 ug | — |
| Subject | SSS06 | Protein / enzyme biologic | 500 ug | — |
| Subject | SSS06 | Protein / enzyme biologic | 800 ug | — |
| Comparator | rhEPO | Protein / enzyme biologic | 36000 iu | — |